Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
D. Brites, R. Silva & A. Brito. (1997) Effect of bilirubin on erythrocyte shape and haemolysis, under hypotonic, aggregating or non-aggregating conditions, and correlation with cell age. Scandinavian Journal of Clinical and Laboratory Investigation 57:4, pages 337-349.
Read now
Read now
Rolf Brodersen & Leo Stern. (1980) Binding of Bilirubin to Albumin. CRC Critical Reviews in Clinical Laboratory Sciences 11:4, pages 307-399.
Read now
Read now
D. Bratlid. (1972) The Effect of Antimicrobial Agents on Bilirubin Binding by Human Erythrocytes. Scandinavian Journal of Clinical and Laboratory Investigation 30:3, pages 331-337.
Read now
Read now
D. Bratlid. (1972) The Effect of Free Fatty Acids, Bile Acids, and Hematin on Bilirubin Binding by Human Erythrocytes. Scandinavian Journal of Clinical and Laboratory Investigation 30:1, pages 107-112.
Read now
Read now
Articles from other publishers (33)
Isha Khurana, Prince Allawadhi, Amit Khurana, Amit Kumar Srivastava, Umashanker Navik, Anil Kumar Banothu & Kala Kumar Bharani. (2021) Can bilirubin nanomedicine become a hope for the management of COVID-19?. Medical Hypotheses 149, pages 110534.
Crossref
Crossref
Thor W. R. Hansen, Ronald J. Wong & David K. Stevenson. (2020) Molecular Physiology and Pathophysiology of Bilirubin Handling by the Blood, Liver, Intestine, and Brain in the Newborn. Physiological Reviews 100:3, pages 1291-1346.
Crossref
Crossref
Domenico Lapenna, Giuliano Ciofani, Sante Donato Pierdomenico, Maria Adele Giamberardino, Sante Ucchino & Giovanni Davì. (2017) Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis. Clinical and Experimental Medicine 18:1, pages 119-124.
Crossref
Crossref
Karri Barabas, Rowan Milner, James Farese, Chris Baylis, Byron Croker, Linda Archer & Christopher Adin. (2008) Hyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat. Anti-Cancer Drugs 19:5, pages 495-502.
Crossref
Crossref
Antony F. McDonagh. (2007) Bilirubin Toxicity to Human Erythrocytes: A More Sanguine View. Pediatrics 120:1, pages 175-178.
Crossref
Crossref
Kristin Kirkby, Chris Baylis, Anupam Agarwal, Byron Croker, Linda Archer & Christopher Adin. (2007) Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo. American Journal of Physiology-Renal Physiology 292:2, pages F888-F894.
Crossref
Crossref
Maria Alexandra Brito, Rui F.M. Silva & Dora Brites. (2006) Bilirubin toxicity to human erythrocytes: A review. Clinica Chimica Acta 374:1-2, pages 46-56.
Crossref
Crossref
Kristin A. Kirkby & Christopher A. Adin. (2006) Products of heme oxygenase and their potential therapeutic applications. American Journal of Physiology-Renal Physiology 290:3, pages F563-F571.
Crossref
Crossref
Thor Willy Ruud Hansen. (2002) Mechanisms of bilirubin toxicity: clinical implications. Clinics in Perinatology 29:4, pages 765-778.
Crossref
Crossref
Maria Alexandra Brito, Carlos D. Brondino, José J.G. Moura & Dora Brites. (2001) Effects of Bilirubin Molecular Species on Membrane Dynamic Properties of Human Erythrocyte Membranes: A Spin Label Electron Paramagnetic Resonance Spectroscopy Study. Archives of Biochemistry and Biophysics 387:1, pages 57-65.
Crossref
Crossref
H. Rashid, Mohammad K. Ali & S Tayyab. (2000) Effect of pH and temperature on the binding of bilirubin to human erythrocyte membranes. Journal of Biosciences 25:2, pages 157-161.
Crossref
Crossref
Brito, Silva, Tiribelli & Brites. (2000) Assessment of bilirubin toxicity to erythrocytes. Implication in neonatal jaundice management. European Journal of Clinical Investigation 30:3, pages 239-247.
Crossref
Crossref
Saad Tayyab & Mohammad K. Ali. (1997) Binding of Bilirubin to Mammalian Erythrocytes. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 118:1, pages 97-103.
Crossref
Crossref
S. Tayyab & M.K. Ali. (1995) Binding of bilirubin to erythrocytes from different mammalian species. Comparative Biochemistry and Physiology Part A: Physiology 111:3, pages 507-509.
Crossref
Crossref
Yair Amit, Shirley Fedunec, Panakkezhum D. Thomas, Mark J. Poznansky & David Schiff. (1990) Bilirubin-neural cell interaction: Characterization of initial cell surface binding leading to toxicity in the neuroblastoma cell line N-115. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1055:1, pages 36-42.
Crossref
Crossref
Dag Bratlid. (1990) How Bilirubin Gets into the Brain. Clinics in Perinatology 17:2, pages 449-465.
Crossref
Crossref
Philip Roth & Richard A. Polin. (1988) Controversial Topics in Kernicterus. Clinics in Perinatology 15:4, pages 965-990.
Crossref
Crossref
G. K. MALIK, G. K. GOEL, P. N. VISHWANATHAN, P. K. MISRA & B. SHARMA. (1986) Free and Erythrocyte-Bound Bilirubin in Neonatal Jaundice. Acta Paediatrica 75:4, pages 545-549.
Crossref
Crossref
T. W. R. HANSEN & D. BRATLID. (1986) Bilirubin and Brain Toxicity. Acta Paediatrica 75:4, pages 513-522.
Crossref
Crossref
Gerard B. Odell & Henry S. Schutta. 1985. Cerebral Energy Metabolism and Metabolic Encephalopathy. Cerebral Energy Metabolism and Metabolic Encephalopathy
229
261
.
F. EBBESEN. (2008) EFFECT OF EXCHANGE TRANSFUSION ON SERUM RESERVE ALBUMIN FOR BINDING OF BILIRUBIN AND INDEX OF SERUM BILIRUBIN TOXICITY. Acta Paediatrica 70:5, pages 643-648.
Crossref
Crossref
Richard B. Krakaur & John W. Scanlon. (1981) Detection of Free Bilirubin and Estimation of Reserve Albumin Binding Capacity. Clinics in Laboratory Medicine 1:2, pages 329-343.
Crossref
Crossref
Inés Ana Gioia, Raquel E. Serrani & J. L. Corchs. (1981) Bilirubin Adsorption In Vitro by Foetal and Adult Human Erythrocytes. Clinical Chemistry and Laboratory Medicine 19:6.
Crossref
Crossref
Rita G. Harper, Concepcion G. Sia & Catherine M.P. Kierney. (1980) Kernicterus 1980: Problems and Practices Viewed from the Perspective of the Practicing Clinician. Clinics in Perinatology 7:1, pages 75-92.
Crossref
Crossref
Leonore Ballowitz. (1980) Bilirubin encephalopathy: Changing concepts. Brain and Development 2:3, pages 219-227.
Crossref
Crossref
Richard P. Wennberg, Charles E. Ahlfors & L.Fraser Rasmussen. (1979) The pathochemistry of kernicterus. Early Human Development 3:4, pages 353-372.
Crossref
Crossref
ANTONY F. McDONAGH. 1979. The Porphyrins. The Porphyrins
293
491
.
L.H.Th.S. Kortbeek & A.C. Booij. (1979) Bilirubin excess, erythrophages and siderophages in differentiation of blood in cerebrospinal fluid. Clinical Neurology and Neurosurgery 81:4, pages 265-279.
Crossref
Crossref
R. BRODERSEN. (2008) PREVENTION OF KERNICTERUS, BASED ON RECENT PROGRESS IN BILIRUBIN CHEMISTRY. Acta Paediatrica 66:5, pages 625-634.
Crossref
Crossref
Kwang-sun Lee, Lawrence M. Gartner, Arthur I. Eidelman & Sudhakar Ezhuthachan. (1977) Unconjugated Hyperbilirubinemia in Very Low Birth Weight Infants. Clinics in Perinatology 4:2, pages 305-320.
Crossref
Crossref
Michael W. Simon, Janice M. Rusnak & Antony J. Mukkada. (1976) Toxicity of bilirubin to Leishmania tropica promastigotes. Experimental Parasitology 39:1, pages 51-58.
Crossref
Crossref
M. Pays & M. Beljean. (1975) Microdetermination of unbound bilirubin in sera. Application to the prevention of kernicterus by estimating the bilirubin-binding capacity of serum albumin. Clinica Chimica Acta 59:2, pages 121-128.
Crossref
Crossref
DAG BRATLID & ASBJØSRN LANGSLET. (2008) DISPLACEMENT OF ALBUMIN‐BOUND BILIRUBIN BY INJECTABLE DIAZEPAM PREPARATIONS IN VITRO. Acta Paediatrica 62:5, pages 510-512.
Crossref
Crossref